XML 35 R21.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 13 - Employee Benefit Plans
12 Months Ended
Dec. 31, 2017
Notes to Financial Statements  
Compensation and Employee Benefit Plans [Text Block]
Note
1
3
. Employee Benefit Plans
 
Defined Benefit Plans
 
The Company maintains
two
nonqualified domestic, noncontributory defined benefit plans (the “Benefit Plans”) for key members of senior management and non-management directors. The Company
’s unfunded Benefit Plans include the Supplemental Executive Retention Plan (“SERP”) and the Directors’ Supplemental Retirement Plan (“Directors’ Plan”). The SERP provides for a defined benefit, at normal retirement age, targeted at
35%
of the participant’s projected final average compensation, subject to a defined maximum annual benefit. Benefits under the SERP generally become payable at age
62.
The Directors’ Plan provides for a defined benefit, at normal retirement age, up to
100%
of the participant’s highest consecutive
three
-year average compensation. Benefits under the Directors’ Plan generally become payable at age
70.
 
The following table presents the
changes in the aggregate actuarial benefit obligation during the periods indicated:
 
   
December 31,
 
   
2017
   
2016
 
(Amounts in thousands)
 
 
 
 
 
 
 
 
Beginning balance
  $
9,181
    $
8,390
 
Plan change
   
258
     
69
 
Service cost
   
231
     
184
 
Interest cost
   
372
     
382
 
Actuarial (gain) loss
   
(48
)    
367
 
Benefits paid
   
(359
)    
(211
)
Ending balance
  $
9,635
    $
9,181
 
 
The following table presents the components of net periodic pension cost and the assumed discount rate
for the periods indicated:
 
   
Year Ended December 31,
 
 
 
2017
   
2016
   
2015
 
(Amounts in thousands, except discount rate)
                       
Service cost
  $
231
    $
184
    $
180
 
Interest cost
   
372
     
382
     
334
 
Amortization of prior service cost
   
228
     
226
     
260
 
Amortization of losses
   
31
     
47
     
66
 
Net periodic cost
  $
862
    $
839
    $
840
 
                         
Assumed discount rate
   
3.85
%    
4.22
%    
4.62
%
 
The following schedule presents the projected benefit payments to be paid under the Benefit Plans, by year, as of
December 31,
201
7:
 
(Amounts in thousands)
       
2018
  $
468
 
2019
   
462
 
2020
   
529
 
2021
   
581
 
2022
   
586
 
2023 through 2027
   
2,924
 
 
Deferred Compensation Plan
 
The Company maintains deferred compensation
agreements with certain current and former officers that provide benefit payments, over various periods, commencing at retirement or death. There were
no
accrued benefits, which are based on the present values of expected payments and estimated life expectancies, as of
December 31, 2017,
compared to
$458
thousand as of
December 31, 2016.
Expenses related to the deferred compensation plan totaled
$11
 thousand in
2017,
$60
thousand in
2016,
and
$60
thousand in
2015.
 
Employee Welfare Plan
 
The Company provides various medical, dental, vision, life, accidental death and dismemberment, and long-term disability insurance benefits to all full-time employees who elect coverage under this program. A
third
-party administrator manages the health plan. Monthly employer and employee contributions are made to a tax-exempt employee benefits trust where the
third
-party administrator
processes and pays claims. As of
December 31, 2017,
stop-loss insurance coverage generally limits the Company’s risk of loss to
$150
thousand for individual claims and
$4.41
million for aggregate claims. Expenses related to the health plan totaled
$3.50
million in
2017,
$3.48
million in
2016,
and
$3.06
million in
2015.
 
Employee Stock Ownership and Savings Plan
 
The Company maintains the Employee Stock Ownership and Savings Plan (“KSOP”) that
consists of a
401
(k) savings feature that covers all employees that meet minimum eligibility requirements. The Company matches employee contributions at levels determined by the Board of Directors annually. These contributions are made in the
first
quarter following each plan year and employees must be employed on the last day of the plan year to be eligible. Matching contributions to qualified deferrals under the
401
(k) savings component of the KSOP totaled
$1.18
million in
2017,
$1.50
million in
2016,
and
$1.53
million in
2015.
The KSOP held
387,935
shares of the Company’s common stock as of
December 31, 2017,
410,384
shares as of
December 31, 2016,
and
428,785
shares as of
December 31, 2015.
Substantially all plan assets are invested in the Company’s common stock.
 
Equity-Based Compensation Plans
 
The Company maintains equity-based compensation plans to promote the long-term success of the Company by encouraging officers, employees, directors, and other individuals performing services for the Company to focus on critical long-range objectives. The Company
’s equity-based compensation plans include the
2012
Omnibus Equity Compensation Plan (
“2012
Plan”),
2004
Omnibus Stock Option Plan,
2001
Director’s Option Plan,
1999
Stock Option Plan, and various other plans obtained through acquisitions. As of
December 31, 2017,
the
2012
Plan was the only plan available for the issuance of future grants. All plans issued or obtained before the
2012
Plan are frozen and
no
new grants
may
be issued; however, any options or awards unexercised and outstanding under those plans remain in effect per their respective terms. The
2012
Plan authorized
600,000
shares available for potential grants of incentive stock options, nonqualified stock options, performance awards, restricted stock, restricted stock units, stock appreciation rights, bonus stock, and stock awards. Grants issued under the
2012
Plan state the period of time the grant
may
be exercised,
not
to exceed more than
ten
years from the date granted. The Company’s Compensation and Retirement Committee determines the vesting period for each grant; however, if
no
vesting period is specified the vesting occurs in
25%
increments on the
first
four
anniversaries of the grant date.
 
The following table presents the pre-tax compensation expense and excess tax benefit recognized in earnings for all equity-based compensation plans
for the periods indicated:
 
   
Year Ended December 31,
 
 
 
2017
   
2016
   
2015
 
(Amounts in thousands)
                       
Pre-tax compensation expense
  $
430
    $
209
    $
110
 
Excess tax benefit
   
17
     
174
     
8
 
 
Stock Options
 
The following table presents stock option activity and related information
for the year ended
December 31, 2017:
 
           
Weighted Average
   
Weighted Average
   
Aggregate
 
 
 
Option
   
Exercise Price
   
Remaining Contractual
   
Intrinsic
 
(Amounts in thousands,
except share and per share data)
 
Shares
   
Per Share
   
Term (Years)
   
Value
 
Outstanding, January 1, 2017
   
200,396
    $
19.73
     
 
     
 
 
Granted
   
22,849
     
24.72
     
 
     
 
 
Exercised
   
(16,185
)    
23.33
     
 
     
 
 
Canceled
   
(6,356
)    
15.83
     
 
     
 
 
Outstanding, December 31, 2017
   
200,704
    $
20.14
     
5.9
    $
1,742
 
Exercisable, December 31, 2017
   
145,536
    $
19.41
     
4.9
    $
1,373
 
 
The following table presents the total options granted and the weighted average assumptions used to estimate the fair value of those options during the periods indicated
:
 
   
Year Ended December 31,
 
 
 
2017
   
2016
   
2015
 
                         
Stock options granted
   
22,849
     
32,768
     
-
 
Grant-date fair value per share
  $
5.79
    $
4.01
     
-
 
Volatility
   
27.86
%    
25.04
%    
-
 
Risk-free rate
   
2.17
%    
1.56
%    
-
 
Expected dividend yield
   
2.99
%    
3.09
%    
-
 
Expected term (in years)
   
6.50
     
6.50
     
-
 
 
The intrinsic value of options exercised
totaled
$84
thousand in
2017,
$434
thousand in
2016,
and
$20
thousand in
2015.
As of
December 31, 2017,
unrecognized compensation cost related to nonvested stock options was
$156
thousand with an expected weighted average recognition period of
1.10
years. The actual compensation cost recognized might differ from this estimate due to various items, including new grants and changes in estimated forfeitures.
 
Restricted Stock Awards
 
The following table presents restricted stock activity and related information
for the year ended
December 31, 2017:
 
           
Weighted Average
 
 
 
Shares
   
Grant-Date Fair Value
 
                 
Nonvested, January 1, 2017
   
27,803
    $
20.59
 
Granted
   
38,500
     
25.69
 
Vested
   
(22,697
)    
23.66
 
Canceled
   
-
     
-
 
Nonvested, December 31, 2017
   
43,606
    $
23.49
 
 
As of
December 31,
201
7,
unrecognized compensation cost related to nonvested restricted stock awards was
$740
thousand with an expected weighted average recognition period of
1.47
years. The actual compensation cost recognized might differ from this estimate due to various items, including new awards granted and changes in estimated forfeitures.